BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31256280)

  • 1. Bright tongue sign in patients with late-onset Pompe disease.
    Karam C; Dimitrova D; Yutan E; Chahin N
    J Neurol; 2019 Oct; 266(10):2518-2523. PubMed ID: 31256280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tongue weakness and atrophy differentiates late-onset Pompe disease from other forms of acquired/hereditary myopathy.
    Jones HN; Hobson-Webb LD; Kuchibhatla M; Crisp KD; Whyte-Rayson A; Batten MT; Zwelling PJ; Kishnani PS
    Mol Genet Metab; 2021 Jul; 133(3):261-268. PubMed ID: 34053870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system involvement in late-onset Pompe disease: clues from neuroimaging and neuropsychological analysis.
    Musumeci O; Marino S; Granata F; Morabito R; Bonanno L; Brizzi T; Lo Buono V; Corallo F; Longo M; Toscano A
    Eur J Neurol; 2019 Mar; 26(3):442-e35. PubMed ID: 30312517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Yield of Chilaiditi's Sign in Advanced-Phase Late-Onset Pompe Disease.
    Takahashi J; Mori-Yoshimura M; Ariga H; Sato N; Nishino I; Takahashi Y
    J Neuromuscul Dis; 2022; 9(5):619-627. PubMed ID: 35964201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset Pompe disease (LOPD): correlations between respiratory muscles CT and MRI features and pulmonary function.
    Gaeta M; Barca E; Ruggeri P; Minutoli F; Rodolico C; Mazziotti S; Milardi D; Musumeci O; Toscano A
    Mol Genet Metab; 2013 Nov; 110(3):290-6. PubMed ID: 23916420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroglossia: A potentially severe complication of late-onset Pompe disease.
    Dupé C; Lefeuvre C; Solé G; Behin A; Pottier C; Duval F; Carlier RY; Prigent H; Lacau St Guily J; Arrassi A; Taouagh N; Hamroun D; Nicolas G; Laforêt P
    Eur J Neurol; 2022 Jul; 29(7):2121-2128. PubMed ID: 35302691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of lingual strength in late-onset Pompe disease.
    Jones HN; Crisp KD; Asrani P; Sloane R; Kishnani PS
    Muscle Nerve; 2015 May; 51(5):731-5. PubMed ID: 25399907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic respiratory muscle function in late-onset Pompe disease.
    Smith BK; Allen S; Mays S; Martin AD; Byrne BJ
    Sci Rep; 2019 Dec; 9(1):19006. PubMed ID: 31831753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation.
    Dubrovsky A; Corderi J; Lin M; Kishnani PS; Jones HN
    Muscle Nerve; 2011 Dec; 44(6):897-901. PubMed ID: 21953123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies.
    Meznaric M; Fumic K; Leonardis L
    J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Evaluation of Upright Posture by x-Ray and 3D Stereophotogrammetry with a New Marker Set Protocol in Late Onset Pompe Disease.
    De Blasiis P; Fullin A; Sansone M; Del Viscovo L; Napolitano F; Terracciano C; Lus G; Melone MAB; Sampaolo S
    J Neuromuscul Dis; 2021; 8(6):979-988. PubMed ID: 34120910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease.
    Horvath JJ; Austin SL; Case LE; Greene KB; Jones HN; Soher BJ; Kishnani PS; Bashir MR
    Muscle Nerve; 2015 May; 51(5):722-30. PubMed ID: 25155446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).
    Montagnese F; Granata F; Musumeci O; Rodolico C; Mondello S; Barca E; Cucinotta M; Ciranni A; Longo M; Toscano A
    J Inherit Metab Dis; 2016 May; 39(3):391-398. PubMed ID: 26830551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature.
    Hobson-Webb LD; Proia AD; Thurberg BL; Banugaria S; Prater SN; Kishnani PS
    Mol Genet Metab; 2012 Aug; 106(4):462-9. PubMed ID: 22664150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
    Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study.
    van der Ploeg A; Carlier PG; Carlier RY; Kissel JT; Schoser B; Wenninger S; Pestronk A; Barohn RJ; Dimachkie MM; Goker-Alpan O; Mozaffar T; Pena LD; Simmons Z; Straub V; Guglieri M; Young P; Boentert M; Baudin PY; Wens S; Shafi R; Bjartmar C; Thurberg BL
    Mol Genet Metab; 2016 Sep; 119(1-2):115-23. PubMed ID: 27473031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward deconstructing the phenotype of late-onset Pompe disease.
    Schüller A; Wenninger S; Strigl-Pill N; Schoser B
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):80-8. PubMed ID: 22253010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body magnetic resonance imaging in late-onset Pompe disease: Clinical utility and correlation with functional measures.
    Khan AA; Boggs T; Bowling M; Austin S; Stefanescu M; Case L; Kishnani PS
    J Inherit Metab Dis; 2020 May; 43(3):549-557. PubMed ID: 31710733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bent spine syndrome as the initial symptom of late-onset Pompe disease.
    Taisne N; Desnuelle C; Juntas Morales R; Ferrer Monasterio X; Sacconi S; Duval F; Sole G; Flipo RM; Lacour A; Vermersch P; Cardon T
    Muscle Nerve; 2017 Jul; 56(1):167-170. PubMed ID: 27862019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pompe disease in Austria: clinical, genetic and epidemiological aspects.
    Löscher WN; Huemer M; Stulnig TM; Simschitz P; Iglseder S; Eggers C; Moser H; Möslinger D; Freilinger M; Lagler F; Grinzinger S; Reichhardt M; Bittner RE; Schmidt WM; Lex U; Brunner-Krainz M; Quasthoff S; Wanschitz JV
    J Neurol; 2018 Jan; 265(1):159-164. PubMed ID: 29181627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.